Open Label Extension Study for Continued Safety and Efficacy Evaluation of Azeliragon in patients with Mild Aszheimer's Disease

Grants and Contracts Details

StatusFinished
Effective start/end date7/17/179/13/18

Funding

  • vTv Therapeutics LLC: $2.00